CYLD and COVID-19: We found that the overwhelming majority of pathways that correlated with dysregulated genes in both COVID-19 and NIDCM are associated with CYLD, and these pathways are primarily pro-plotting, pro-cell aggregation, and pro-inflammation (See Appendix A, Figure A2A), supporting the possibility that CYLD is released in response to inflammation.